Clinical Trial Update: Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic Kidney Disease in Patients With Diabetes. [NA]

View source ↗

Summary

A clinical trial is studying an oral uremic toxin absorbent combined with probiotics to modulate systemic inflammation and slow the progression of chronic kidne…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Diabetes Mellitus
• Diabetic Nephropathy

Drugs mentioned

• Oral uremic toxin absorbent
• Probiotics

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Oral Uremic Toxin Absorbent | NA | Status: RECRUITING